| Dr Michael Leroy Rains, MD | |
|
76 Peachtree Rd Ste 120, Asheville, NC 28803-5041 | |
| (828) 677-3128 | |
| (828) 222-6042 |
| Full Name | Dr Michael Leroy Rains |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 76 Peachtree Rd Ste 120, Asheville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275851032 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2018-01014 (North Carolina) | Primary |
| Entity Name | Advanced Dermatology And Skin Surgery Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215990700 PECOS PAC ID: 9830115997 Enrollment ID: O20051018000681 |
News Archive
Dr. Martin Hickey, Chairman of the National Alliance of State Health CO-OPs' Board of Directors, made the following statement regarding the recent announcement that the Iowa Insurance Division is taking over CoOportunity Health.
Rigel Pharmaceuticals, Inc. today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease.
The US Food and Drug Administration (FDA) has now approved Lipsovir, i.e. granted Medivir's New Drug Application (NDA) for the use of acyclovir and hydrocortisone for early treatment of recurrent cold sores to decreases the risk of cold sores, and to shorten the healing time for those cold sores which are not prevented.
Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.
› Verified 7 days ago
| Entity Name | Beacon Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598486565 PECOS PAC ID: 1850767377 Enrollment ID: O20221024002727 |
News Archive
Dr. Martin Hickey, Chairman of the National Alliance of State Health CO-OPs' Board of Directors, made the following statement regarding the recent announcement that the Iowa Insurance Division is taking over CoOportunity Health.
Rigel Pharmaceuticals, Inc. today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease.
The US Food and Drug Administration (FDA) has now approved Lipsovir, i.e. granted Medivir's New Drug Application (NDA) for the use of acyclovir and hydrocortisone for early treatment of recurrent cold sores to decreases the risk of cold sores, and to shorten the healing time for those cold sores which are not prevented.
Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Leroy Rains, MD Po Box 63249, Charlotte, NC 28263-3249 Ph: (828) 677-3128 | Dr Michael Leroy Rains, MD 76 Peachtree Rd Ste 120, Asheville, NC 28803-5041 Ph: (828) 677-3128 |
News Archive
Dr. Martin Hickey, Chairman of the National Alliance of State Health CO-OPs' Board of Directors, made the following statement regarding the recent announcement that the Iowa Insurance Division is taking over CoOportunity Health.
Rigel Pharmaceuticals, Inc. today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease.
The US Food and Drug Administration (FDA) has now approved Lipsovir, i.e. granted Medivir's New Drug Application (NDA) for the use of acyclovir and hydrocortisone for early treatment of recurrent cold sores to decreases the risk of cold sores, and to shorten the healing time for those cold sores which are not prevented.
Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.
› Verified 7 days ago
Gina Rae Singleton, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 600 Alliance Ct, Suite 200, Asheville, NC 28806 Phone: 828-565-0560 Fax: 828-565-0561 | |
Alison Lyke, MD Dermatology Medicare: Medicare Enrolled Practice Location: 281 Mcdowell St, Asheville, NC 28803 Phone: 828-252-5676 | |
Dr. Gerald L Stoker, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Vamc Medicine Service, Asheville, NC 28805 Phone: 828-299-2515 Fax: 828-288-5885 | |
Dr. Lisa L May, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 80 Peachtree Rd Ste 106, Asheville, NC 28803 Phone: 828-232-5222 Fax: 828-258-3003 | |
Heather Joy Higgins, D.O Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 Hendersonville Rd Ste 107, Asheville, NC 28803 Phone: 828-222-7022 | |
Jessika Davis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16 Medical Park Dr, Asheville, NC 28803 Phone: 828-274-4880 |